|
| Category | FY | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS077239-04
|
|
Epitope-Specific Targeting of Tau Aggregates.
|
SIGURDSSON, EINAR
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$449,080
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG022304-10
|
|
fMRI as an Imaging Biomarker for Preclinical Alzheimer's Disease
|
RAO, STEPHEN
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$374,592
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG026720-08
|
|
Changes in Sleep and Cognition in Older Women
|
STONE, KATIE
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
CA
|
$588,705
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG041781-03
|
|
Reducing Agitation in Dementia Patients at Home: The Customized Activity Trial
|
GITLIN, LAURA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$611,304
|
|
Alzheimer's Disease
|
2015
|
NIDCR
|
7K23DE022470-03
|
|
Development and Validation of an Instrument to Assess Cognitive Function Regulati
|
CHEN, XI
|
UNIVERSITY OF IOWA
|
IA
|
$128,287
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG012101-20
|
|
MRI Progression Markers of Cognitive Decline in the Elderly
|
DE LEON, MONY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$618,546
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG022374-10
|
|
Biomarkers in Early Alzheimer's Disease (AD).
|
DE LEON, MONY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$620,385
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5F32AG044953-02
|
|
Insulin resistance, amyloid, and memory in normal aging and preclinical AD
|
MORRIS, JILL
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$57,121
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5F32AG044954-02
|
|
Role of exosomes in amyloid clearance and plaque formation in AD.
|
DINKINS, MICHAEL
|
GEORGIA REGENTS UNIVERSITY
|
GA
|
$56,042
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R21AG046626-01A1
|
|
In vivo permeability of the human blood-cerbrospinal fluid barrier in dementia
|
ANDERSON, VALERIE
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$230,352
|
|
Alzheimer's Disease
|
2015
|
NIMH
|
5R01MH054846-19
|
|
Geriatric Depression: Risk Factors for Adverse Outcomes
|
STEFFENS, DAVID
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$500,550
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5K01AG041211-02
|
|
Quantitative MR Microscopy of Phenotypic Biomarkers in Alzheimer's Disease
|
BADEA, ALEXANDRA
|
DUKE UNIVERSITY
|
NC
|
$128,476
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5K24AG046373-02
|
|
Risk factors and prevention targets for abnormal cognitive aging
|
JEFFERSON, ANGELA
|
VANDERBILT UNIVERSITY
|
TN
|
$164,429
|
|
Alzheimer's Disease
|
2015
|
NIGMS
|
5R01GM101136-03
|
|
Structural Studies of GxGD Membrane Protease FlaK
|
HA, YA
|
YALE UNIVERSITY
|
CT
|
$316,350
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5K01AG046374-02
|
|
GENETIC DISRUPTION OF TAU METABOLISM IN TAUOPATHIES
|
KARCH, CELESTE
|
WASHINGTON UNIVERSITY
|
MO
|
$113,700
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5F31NS083258-02
|
|
Polarized transport in nervous system development and disease in zebrafish
|
CAMPBELL, PHILIP
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
NY
|
$43,120
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5U19AG010483-24
|
7824
|
ADMINISTRATIVE CORE
|
AISEN, PAUL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$1,744,623
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5U19AG010483-24
|
7825
|
BIOSTAT CORE
|
THOMAS, RON
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$196,708
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5U19AG010483-24
|
7826
|
INFORMATICS CORE
|
AISEN, PAUL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$262,290
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5U19AG010483-24
|
7827
|
CLINICAL OPERATIONS CORE
|
AISEN, PAUL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$486,091
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5U19AG010483-24
|
7828
|
MED & SAFETY CORE
|
RAMAN, REMA
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$992,513
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5U19AG010483-24
|
7829
|
RECRUITMENT CORE
|
SANO, MARY
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$244,148
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5U19AG010483-24
|
7830
|
BIOMARKER CORE
|
RISSMAN, ROBERT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$225,185
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5U19AG010483-24
|
7831
|
IMAGING CORE
|
BREWER, JAMES
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$346,282
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5U19AG010483-24
|
7832
|
ANTI-AMYLOID TREATMENT IN ASYMPTOMATIC ALZHEIMERS DISEASE
|
SPERLING, REISA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$3,987,763
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5K24AG033640-07
|
|
Midcareer Mentoring Award for Patient-Oriented Research in Aging
|
MITCHELL, SUSAN
|
HEBREW REHABILITATION CENTER FOR AGED
|
MA
|
$179,916
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5U19AG010483-24
|
7833
|
EXERCISE TRAIL
|
BAKER, LAURA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$1,445,276
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5U19AG010483-24
|
7834
|
PRAZOSIN FOR AGITATION IN ALZHEIMER'S DISEASE
|
PESKIND, ELAINE
|
UNIVERSITY OF WASHINGTON
|
WA
|
$1,191,547
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5U19AG010483-24
|
7835
|
CSF SAMPLING STUDY
|
GALASKO, DOUGLAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$270,890
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5F32AG044076-03
|
|
Understanding visual working memory in Alzheimer's disease
|
KO, PHILIP
|
VANDERBILT UNIVERSITY
|
TN
|
$61,619
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS079796-03
|
|
Gamma-Secretase and Myelin: A Paradigm Shift in Brain Disorders
|
YU, GANG
|
UT SOUTHWESTERN MEDICAL CENTER
|
TX
|
$347,813
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R00AG039482-04
|
|
Characterization of ATXN1 in APP processing and AD pathogenesis
|
ZHANG, CAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$241,529
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P01AG027956-07
|
6474
|
Intracellular calcium channels as targets of estrogen and progesterone
|
KOULEN, PETER
|
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
|
TX
|
$240,350
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5K99AG044445-02
|
|
Involvement of myelin integrity in Alzheimer's disease pathogenesis
|
BACHSTETTER, ADAM
|
UNIVERSITY OF KENTUCKY
|
KY
|
$85,661
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5F31AG046055-02
|
|
NR4A Receptors in Alzheimer's disease
|
SKERRETT, REBECCA
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$43,120
|
|
Alzheimer's Disease
|
2015
|
NIMH
|
5R37MH065635-14
|
|
Gene Expression in Long-Term Memory
|
ALBERINI, CRISTINA
|
NEW YORK UNIVERSITY
|
NY
|
$478,050
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1F32AG048690-01
|
|
Organellar pH shifts in Alzheimer's disease from simulation & experiment
|
PLOETZ, ELIZABETH
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$53,264
|
|
Alzheimer's Disease
|
2015
|
NHLBI
|
5K99HL118154-02
|
|
Cerebral blood flow, connectivity and cognition: the effect of age and exercise
|
BARNES, JILL
|
MAYO CLINIC ROCHESTER
|
MN
|
$90,000
|
|
Alzheimer's Disease
|
2015
|
NHGRI
|
5U54HG003273-12
|
|
The Human Genome Sequencing Center
|
GIBBS, RICHARD
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$18,139,328
|
|
Alzheimer's Disease
|
2015
|
NHLBI
|
5R01HL111062-04
|
|
Endothelial Dysfunction In The Cerebral Circulation
|
KATUSIC, ZVONIMIR
|
MAYO CLINIC ROCHESTER
|
MN
|
$450,850
|
|
Alzheimer's Disease
|
2015
|
NIBIB
|
5R01EB014894-03
|
|
MR-assisted PET data optimization for neuroimaging studies
|
CATANA, CIPRIAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$660,528
|
|
Alzheimer's Disease
|
2015
|
NIDCD
|
5R01DC011492-05
|
|
Bilingual Alzheimer's Disease
|
GOLLAN, TAMAR
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$439,303
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS037918-17
|
|
Novel Lysosomal Enzyme Deficient in Batten Disease
|
LOBEL, PETER
|
RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL
|
NJ
|
$347,813
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS074536-05
|
|
Validating a Novel Lipid Phosphatase Target in Alzheimer's Disease
|
KIM, TAE-WAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$350,000
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS075685-04
|
|
Model for SorCS1-mediated Diabetes with Dementia
|
GANDY, SAMUEL
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$370,781
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG046646-02
|
|
The Pharmacological Enhancement of Sleep for Memory Improvement
|
MEDNICK, SARA
|
UNIVERSITY OF CALIFORNIA RIVERSIDE
|
CA
|
$302,252
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS078304-04
|
|
The glymphatic system, a new concept in glia biology
|
NEDERGAARD, MAIKEN
|
UNIVERSITY OF ROCHESTER
|
NY
|
$337,969
|
|
Alzheimer's Disease
|
2015
|
NIMH
|
5R01MH094146-05
|
|
Neural representations of external stimuli in the lateral entorhinal cortex
|
KNIERIM, JAMES
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$410,000
|
|
Alzheimer's Disease
|
2015
|
NIMH
|
5R01MH094607-02
|
|
Axonal Transport and Long-Term Memory Storage
|
PUTHANVEETTIL, SATHYANARAYANANAN
|
SCRIPPS FLORIDA
|
FL
|
$460,750
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS071011-05
|
|
THE ROLE OF A-BETA SPECIES IN VASCULAR SMOOTH MUSCLE CELL AND CEREBRAL ARTERIOLE
|
ZIPFEL, GREGORY
|
WASHINGTON UNIVERSITY
|
MO
|
$332,500
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG042611-03
|
|
Pleiotropic and Interaction Effects on Alzheimer's disease Risk and Progression
|
KAUWE, JOHN
|
BRIGHAM YOUNG UNIVERSITY
|
UT
|
$266,350
|
|
Alzheimer's Disease
|
2015
|
NIGMS
|
5R01GM065830-11
|
|
Multi-scale observation and modeling of IP3/Ca signaling
|
PEARSON, JOHN
|
LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB
|
NM
|
$914,294
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS073899-05
|
|
The Hsp90 cochaperone FKBP51 regulates tau structure and function
|
DICKEY, CHAD
|
UNIVERSITY OF SOUTH FLORIDA
|
FL
|
$373,794
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R03AG046614-02
|
|
Diabetes and Obesity: Associations with Cognition, Neuropathology, and Longevity
|
GELBER, REBECCA
|
PACIFIC HEALTH RESEARCH/ EDUCATION INST
|
HI
|
$67,635
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS041783-14
|
|
Role of Presenilins in the Synapse
|
SHEN, JIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$378,105
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG044499-02
|
|
Mint Adaptor Proteins in APP Binding and Processing
|
HO, ANGELA
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
MA
|
$325,517
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R01AG048793-01
|
|
Alzheimer's Brain-Seeded Abeta Fibrils
|
MEREDITH, STEPHEN
|
UNIVERSITY OF CHICAGO
|
IL
|
$441,098
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5F32AG044054-03
|
|
Deficits in top-down processes during episodic memory in aging and preclinical AD
|
MORMINO, ELIZABETH
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$57,257
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS034467-17
|
|
Alzheimer's Abeta, apolipoproteins and blood-brain barrier
|
ZLOKOVIC, BERISLAV
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$598,742
|
|
Alzheimer's Disease
|
2015
|
NIA
|
2P01AG002132-34A1
|
8435
|
Core B: Science
|
GILES, KURT
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$220,890
|
|
Alzheimer's Disease
|
2015
|
NIA
|
2P01AG002132-34A1
|
8436
|
Core C: Pathology
|
DEARMOND, STEPHEN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$214,395
|
|
Alzheimer's Disease
|
2015
|
NIA
|
2P01AG002132-34A1
|
8438
|
Project 1: Abeta, tau and PrP prions causing neurodegenerative diseases
|
PRUSINER, STANLEY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$367,948
|
|
Alzheimer's Disease
|
2015
|
NIA
|
2P01AG002132-34A1
|
8439
|
Project 2: Structural studies of prions
|
STUBBS, GERALD
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$266,315
|
|
Alzheimer's Disease
|
2015
|
NIA
|
2P01AG002132-34A1
|
8440
|
Project 3: Assembly and structures of Abeta peptides.
|
DEGRADO, WILLIAM
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$298,852
|
|
Alzheimer's Disease
|
2015
|
NIA
|
2P01AG002132-34A1
|
8441
|
Project 4: Structural modeling of Abeta, tau and PrP prion self-assembly
|
SALI, ANDREJ
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$220,892
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R13AG042201-04
|
|
Human Amyloid Imaging (HAI) Meeting
|
JOHNSON, KEITH
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$35,000
|
|
Alzheimer's Disease
|
2015
|
NIMH
|
5R01MH094626-05
|
|
Cholinergic control of neural network function
|
MCQUISTON, ADAM
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$373,750
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS052233-10
|
|
Engineering Form and Function in Neuronal Networks
|
WHEELER, BRUCE
|
UNIVERSITY OF FLORIDA
|
FL
|
$356,905
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS081068-03
|
|
The role of apoE and APOE genotype in amyloid-beta clearance after TBI
|
BURNS, MARK
|
GEORGETOWN UNIVERSITY
|
DC
|
$358,917
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS082413-03
|
|
Circadian dysfunction and GSK3 in neurodegenerative disease
|
GAMBLE, KAREN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$292,978
|
|
Alzheimer's Disease
|
2015
|
NIBIB
|
5R00EB009106-04
|
|
In vivo Amyloid-Beta Imaging in Mouse Brain Using Stochastic Object Models
|
SHOKOUHI, SEPIDEH
|
VANDERBILT UNIVERSITY
|
TN
|
$241,855
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R21NS087460-02
|
|
Microglia in obesity-induced synapse loss and cognitive decline
|
GOULD, ELIZABETH
|
PRINCETON UNIVERSITY
|
NJ
|
$201,250
|
|
Alzheimer's Disease
|
2015
|
NIGMS
|
5R01GM097562-04
|
|
Mimicry of Amyloid Oligomers
|
NOWICK, JAMES
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
CA
|
$285,402
|
|
Alzheimer's Disease
|
2015
|
NIDCD
|
5R01DC013063-02
|
|
Semantic Memory and Language Learning in Alzheimer's Disease and Semantic Dementi
|
REILLY, JAMES
|
TEMPLE UNIV OF THE COMMONWEALTH
|
PA
|
$469,379
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS038486-16
|
|
Structural study of Eph receptors and ephrins
|
NIKOLOV, DIMITAR
|
SLOAN-KETTERING INST CAN RESEARCH
|
NY
|
$386,750
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS084324-02
|
|
Mechanisms of abeta induced dysfunction in hippocampal neuronal circuitry
|
KOO, EDWARD
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$530,088
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R01AG048923-01
|
|
Characterization of ApoE4 Induced Phospholipid Dysregulation in AD Pathogenesis
|
CAI, DONGMING
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$339,951
|
|
Alzheimer's Disease
|
2015
|
NIAMS
|
5R01AR048155-11
|
|
Functional Amyloid in Melansome Biogenesis
|
MARKS, MICHAEL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
PA
|
$357,000
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R21NS083692-02
|
|
Leptin, Obesity, and Stroke
|
MURPHY, MICHAEL
|
UNIVERSITY OF KENTUCKY
|
KY
|
$187,865
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R01AG049002-01
|
|
Noninvasive Stimulation to Improve Hippocampal-Dependent Memory in Older Adults
|
VOSS, JOEL
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$416,782
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P01AG027296-07
|
5771
|
STUDY OF HOSPITALS STAFFING ATTENDING PHYSICIAN ROLE FOR PATIENTS AT END OF LIFE
|
TENO, JOAN
|
BROWN UNIVERSITY
|
RI
|
$214,151
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS079374-03
|
|
Role of Tau Cleavage in Tauopathy
|
ASHE, KAREN
|
UNIVERSITY OF MINNESOTA
|
MN
|
$361,150
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R01AG048927-01
|
|
Alzheimer Disease Genetic Architecture in African Americans
|
FARRER, LINDSAY
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$652,832
|
|
Alzheimer's Disease
|
2015
|
NIMH
|
5R01MH074006-10
|
|
Forebrain-Cerebellum Interactions in Trace Conditioning
|
MAUK, MICHAEL
|
UNIVERSITY OF TEXAS, AUSTIN
|
TX
|
$380,882
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS041787-14
|
|
Kinases Linking Abeta and Tau to Synaptic Dysfunction
|
MUCKE, LENNART
|
J. DAVID GLADSTONE INSTITUTES
|
CA
|
$462,472
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R21NS078363-02
|
|
Macrophage-dependent regulation of neurotoxic APP fragments in a model system
|
COPENHAVER, PHILIP
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$192,500
|
|
Alzheimer's Disease
|
2015
|
NIMH
|
5R01MH080378-07
|
|
Role of PAR-1 Kinase in Synaptogenesis
|
LU, BINGWEI
|
STANFORD UNIVERSITY
|
CA
|
$401,250
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1K99AG049056-01
|
|
CD33 and Alzheimer's Disease: from Biology to Therapy
|
GRICIUC, ANA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$137,160
|
|
Alzheimer's Disease
|
2015
|
NHLBI
|
5R01HL111516-04
|
|
Vascular Factors Underlying Abnormal Cognitive Aging
|
JEFFERSON, ANGELA
|
VANDERBILT UNIVERSITY
|
TN
|
$384,150
|
|
Alzheimer's Disease
|
2015
|
NIMH
|
5R01MH074736-09
|
|
Mechanism Underlying Memory Stabilization
|
ALBERINI, CRISTINA
|
NEW YORK UNIVERSITY
|
NY
|
$625,560
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R03AG049394-01
|
|
Alpha1A-Adrenoceptors in Cognition
|
PEREZ, DIANNE
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$79,250
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS083704-02
|
|
The role of inflammasome signaling in tauopathies
|
BHASKAR, KIRAN
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
NM
|
$330,313
|
|
Alzheimer's Disease
|
2015
|
OD
|
1K01OD019919-01
|
|
Investigating molecular mechanisms of cross-species prion transmission
|
KURT, TIMOTHY
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$130,124
|
|
Alzheimer's Disease
|
2015
|
NCI
|
5R01CA181360-02
|
|
Clustered semi-competing risks analysis in quality of end-of-life care studies
|
HANEUSE, SEBASTIEN
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
MA
|
$454,222
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R03NS087290-02
|
|
Exploring a role for LINE1 retrotransposons in neurodegenerative disease
|
GOODIER, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$81,000
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R21AG049196-01
|
|
A machine learning approach to identify Alzheimer's disease therapeutic targets
|
LEE, SU-IN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$228,861
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R01AG047649-01A1
|
|
Novel Detection of Early Cognitive and Functional Impairment in the Elderly
|
LOEWENSTEIN, DAVID
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$582,363
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R21AG049220-01
|
|
Selective age-related vulnerability in human perirhinal and lateral entorhinal cortices
|
YASSA, MICHAEL
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
CA
|
$231,750
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5K08NS087121-02
|
|
Investigating RNA splicing factor aggregations in Alzheimer's disease and CTE
|
HALES, CHADWICK
|
EMORY UNIVERSITY
|
GA
|
$160,920
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R21AG049216-01
|
|
Empowering Diffusion MRI Measures by Integrating White and Grey Matter Morphology
|
WANG, YALIN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$182,047
|
|
Alzheimer's Disease
|
2015
|
NIMH
|
5R01MH097892-03
|
|
Brain aging and treatment response in geriatric depression
|
LAVRETSKY, HELEN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$686,219
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG028709-09
|
|
Amyloid ion channels to design therapeutics for neurodegenerative diseases
|
LAL, RATNESHWAR
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$279,780
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R01AG049402-01
|
|
Extracellular tau oligomers and Alzheimer disease
|
ARANCIO, OTTAVIO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$328,000
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P01AG017586-15
|
8572
|
CLINICAL CORE
|
GROSSMAN, MURRAY
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$233,061
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P01AG017586-15
|
8574
|
NEUROPATHOLOGY CORE
|
TROJANOWSKI, JOHN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$104,130
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P01AG017586-15
|
8576
|
GENETIC MODIFIERS OF TAUOPATHIES
|
SCHELLENBERG, GERARD
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$263,833
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P01AG017586-15
|
8577
|
MECHANISMS OF PATHOGENESIS
|
LEE, VIRGINIA
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$255,943
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P01AG017586-15
|
8578
|
COGNITIVE AND NEURAL IMPAIRMENT IN FTLD
|
GROSSMAN, MURRAY
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$274,665
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P01AG017586-15
|
8579
|
PATHOLOGIC MODIFIERS OF TDP-43 PROTEINOPATHIES
|
TROJANOWSKI, JOHN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$281,339
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P01AG016765-15
|
8199
|
Estrogen-regulated Plasticity of Hippocampal Neurons
|
MCEWEN, BRUCE
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$278,483
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG017753-14
|
|
Tyrosine phosphorylation in Alzheimer's disease
|
LEE, GLORIA
|
UNIVERSITY OF IOWA
|
IA
|
$300,263
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS075075-04
|
|
Determinants of Neurodegenerative Decline in Primary Progressive Aphasia
|
ROGALSKI, EMILY
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$338,674
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG021173-09
|
|
Identifying and characterizing gene(s) involved in beta-amyloid production.
|
XU, HUAXI
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
CA
|
$387,757
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG022983-10
|
|
Cognitive and Behavioral Control in FTD
|
KRAMER, JOEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$337,836
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG034962-05
|
|
Cardiac function as a mechanism for maladaptive brain aging
|
JEFFERSON, ANGELA
|
VANDERBILT UNIVERSITY
|
TN
|
$850,038
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG036772-05
|
|
Subcortical Vascular Cognitive Impairment-A Longitudinal Perfusion Imaging Study
|
SILBERT, LISA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$306,229
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG038471-05
|
|
Cognitive and Neural Correlates of the Picture Superiority Effect in Alzheimer's.
|
ALLY, BRANDON
|
VANDERBILT UNIVERSITY
|
TN
|
$310,206
|
|
Alzheimer's Disease
|
2015
|
NIBIB
|
5R01EB000768-13
|
|
Multiphoton microscopy for in vivo neural imaging
|
BACSKAI, BRIAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$501,298
|
|
Alzheimer's Disease
|
2015
|
NIGMS
|
5R01GM101066-03
|
|
Tau-mediated regulation of axonal transport
|
BERGER, CHRISTOPHER
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
VT
|
$353,041
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS046673-12
|
|
Regulation of Protein Trafficking in Neurodegeneration
|
XU, HUAXI
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
CA
|
$390,975
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS086947-02
|
|
Memory processing after neuron loss in the entorhinal cortex and hippocampus
|
LEUTGEB, STEFAN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$328,254
|
|
Alzheimer's Disease
|
2015
|
NIGMS
|
1P20GM109025-01A1
|
5771
|
Core B: The Clinical and Translational Research Core
|
ZHONG, KATE
|
CLEVELAND CLINIC FOUNDATION
|
OH
|
$573,107
|
|
Alzheimer's Disease
|
2015
|
NIGMS
|
1P20GM109025-01A1
|
5773
|
Project 1: The relationship between Neuropsychological Testing and MRI, PET, and
|
BANKS, SARAH
|
CLEVELAND CLINIC FOUNDATION
|
OH
|
$298,331
|
|
Alzheimer's Disease
|
2015
|
NIGMS
|
1P20GM109025-01A1
|
5775
|
Project 3: Immune Markers Linking Pathogenesis in Animal Models and Human Neurodegenerative Disease
|
KINNEY, JEFFERSON
|
CLEVELAND CLINIC FOUNDATION
|
OH
|
$445,204
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R01AG045264-01A1
|
|
Diets rich in palmitate increase Alzheimers disease risk by activating CHOP gene
|
GHRIBI, OTHMAN
|
UNIVERSITY OF NORTH DAKOTA
|
ND
|
$283,925
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R15AG046915-01A1
|
|
Determining the Mechanisms Governing Transmissibility Among Amyloid-beta Oligomers
|
RANGACHARI, VIJAY
|
UNIVERSITY OF SOUTHERN MISSISSIPPI
|
MS
|
$368,479
|
|
Alzheimer's Disease
|
2015
|
NEI
|
5R01EY022350-03
|
|
Neural mechanisms for landmark-based navigation
|
EPSTEIN, RUSSELL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$386,136
|
|
Alzheimer's Disease
|
2015
|
NIGMS
|
5R01GM079097-08
|
|
Chromatin Degradation During Apoptosis
|
XUE, DING
|
UNIVERSITY OF COLORADO
|
CO
|
$271,632
|
|
Alzheimer's Disease
|
2015
|
NCI
|
1R03CA191559-01
|
|
Machine Learning Comparison of Brain Anatomy in Cancer and Alzheimer's Disease
|
KESLER, SHELLI
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$80,000
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG023801-10
|
|
Pharmaconeuropathology of Brain Aging and Dementia
|
SONNEN, JOSHUA
|
UNIVERSITY OF UTAH
|
UT
|
$300,661
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R44AG044234-03
|
|
Instrument for Single Molecule Sequencing of Alzheimer's-Relevant Genomic Oxidati
|
KOLODZIEJSKI, NOAH
|
RADIATION MONITORING DEVICES, INC.
|
MA
|
$542,958
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS079339-04
|
|
BACE1 inhibition in injured peripheral nerve and a neuropathy mouse models
|
FARAH, MOHAMED
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$354,375
|
|
Alzheimer's Disease
|
2015
|
NINR
|
5F32NR014777-02
|
|
The Neural Basis of Apathy in Frontotemporal Degeneration: A Longitudinal Study
|
MASSIMO, LAUREN
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
PA
|
$55,106
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
7F32NS087805-02
|
|
Screening and Immunization: A Novel Approach to Tau Antibody Therapeutics
|
FURMAN, JENNIFER
|
UT SOUTHWESTERN MEDICAL CENTER
|
TX
|
$54,194
|
|
Alzheimer's Disease
|
2015
|
NIGMS
|
5SC3GM103706-03
|
|
Design and development of 5-HT7 receptor agonists
|
BONDAREV, MIKHAIL
|
HAMPTON UNIVERSITY
|
VA
|
$111,000
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R01AG049456-01
|
|
Proteostasis and secondary proteinopathy in AD and FTD
|
BORCHELT, DAVID
|
UNIVERSITY OF FLORIDA
|
FL
|
$307,500
|
|
Alzheimer's Disease
|
2015
|
NIBIB
|
2R01EB008374-05A1
|
|
4D Software Tools for Longitudinal Prediction of Brain Disease
|
SHEN, DINGGANG
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$477,101
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5U01AG041140-04
|
|
GABA-A alpha-5 agonists for the treatment of amnestic Mild Cognitive Impairment
|
ROSENZWEIG-LIPSON, SHARON
|
AGENEBIO, INC.
|
MD
|
$376,259
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG044420-03
|
|
Roles of SN27 in regulating glutamate receptors during neurodegeneration
|
XU, HUAXI
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
CA
|
$387,757
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R21NS084217-02
|
|
A transgenic model to study Bif-1 mediated neuroprotection in injury and disease
|
MORRISON, RICHARD
|
UNIVERSITY OF WASHINGTON
|
WA
|
$231,750
|
|
Alzheimer's Disease
|
2015
|
NIMH
|
2R01MH060013-16
|
|
Neuromodulation and Cortical Memory Function
|
HASSELMO, MICHAEL
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
MA
|
$387,337
|
|
Alzheimer's Disease
|
2015
|
NIA
|
2RF1AG015473-16A1
|
|
Genetic Studies of Alzheimer's Disease in Caribbean Hispanics
|
MAYEUX, RICHARD
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$2,553,177
|
|
Alzheimer's Disease
|
2015
|
NINR
|
5R01NR014737-02
|
|
Supporting Family Caregivers with Technology for Dementia Home Care (FamTechCare)
|
WILLIAMS, KRISTINE
|
UNIVERSITY OF IOWA
|
IA
|
$463,271
|
|
Alzheimer's Disease
|
2015
|
NIMH
|
2R01MH060941-15
|
|
Event-related Neuroimaging of Human Memory Formation
|
SCHACTER, DANIEL
|
HARVARD UNIVERSITY
|
MA
|
$422,500
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R01AG046928-01A1
|
|
Effects of physical activity on brain function and network connectivity in MCI
|
PA, JUDY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$499,401
|
|
Alzheimer's Disease
|
2015
|
NIMH
|
5R01MH055687-20
|
|
Associative Processes in Episodic Memory
|
KAHANA, MICHAEL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$433,192
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
2R01NS023945-23
|
|
AFFERENT REGULATION OF CHOLINERGIC FOREBRAIN NEURONS
|
ZABORSZKY, LASZLO
|
RUTGERS THE STATE UNIV OF NJ NEWARK
|
NJ
|
$542,914
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R01AG047596-01A1
|
|
Mapping interindividual variation in the aging connectome
|
COLCOMBE, STAN
|
NATHAN S. KLINE INSTITUTE FOR PSYCH RES
|
NY
|
$716,938
|
|
Alzheimer's Disease
|
2015
|
NINR
|
5R01NR014430-03
|
|
New York City Hispanic Dementia Caregiver Research Program (NHiRP)
|
LUCHSINGER, JOSE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$529,336
|
|
Alzheimer's Disease
|
2015
|
NIMH
|
5R01MH072567-09
|
|
HIV-1 and amyloid beta interactions at the blood-brain barrier
|
TOBOREK, MICHAL
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$363,375
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R21AG045606-01A1
|
|
Probing the Intracellular Environment in Normal Aging Using Magnetic Resonance
|
MARJANSKA, MALGORZATA
|
UNIVERSITY OF MINNESOTA
|
MN
|
$228,000
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS082650-03
|
|
Role of Cholinergic-Glutamatergic Co-transmission in Forebrain Circuits
|
SEAL, REBECCA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$334,648
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R21AG044712-02
|
|
Tangle propagation in preclinical AD
|
COUNTS, SCOTT
|
MICHIGAN STATE UNIVERSITY
|
MI
|
$223,259
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1K99AG047282-01A1
|
|
Insulin Resistance, Biomarkers of Brain Function, and Intermittent Calorie Restriction
|
WILLETTE, AURIEL
|
IOWA STATE UNIVERSITY
|
IA
|
$134,730
|
|
Alzheimer's Disease
|
2015
|
NIMH
|
5F31MH102022-02
|
|
Optogenetic Manipulation of Hippocampal Rhythms, Encoding, and Retrieval
|
CLIMER, JASON
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
MA
|
$31,078
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R37NS034007-22
|
|
eIF2alpha Phosphorylation in Synaptic Plasticity, Memory, and Brain Disorders
|
KLANN, ERIC
|
NEW YORK UNIVERSITY
|
NY
|
$462,771
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS074804-05
|
|
The role of fractalkine signaling in neurodegenerative disease
|
LAMB, BRUCE
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$343,438
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5F32NS080320-03
|
|
Effects of Altered Glucose Utilization on AB Levels and Functional Connectivity
|
MACAULEY-RAMBACH, SHANNON
|
WASHINGTON UNIVERSITY
|
MO
|
$15,136
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS087568-02
|
|
13C MRS Studies of Brain Mitochondrial Metabolism in Insulin Resistance
|
ROTHMAN, DOUGLAS
|
YALE UNIVERSITY
|
CT
|
$418,962
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R21AG047505-01A1
|
|
Exploiting PrP for the diagnosis and treatment of protein aggregation diseases
|
WALSH, DOMINIC
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$221,823
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1K23AG044434-01A1
|
|
White Matter Tract Integrity biomarkers of neurodegeneration in aging and MCI
|
BENITEZ, ANDREANA
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$162,864
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1K01AG047279-01A1
|
|
Pre-clinical testing of lenalidomide as pleiotropic therapeutics of Alzheimer's disease
|
DECOURT, BORIS
|
BANNER HEALTH
|
AZ
|
$106,763
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1K23AG041214-01A1
|
|
Relation of estrogen pathway genes to cognitive decline in elderly women and men
|
JANICKI, SARAH
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$132,300
|
|
Alzheimer's Disease
|
2015
|
NINR
|
5R01NR014434-03
|
|
A Tailored Technology Intervention for Diverse Family Caregivers of AD Patients
|
CZAJA, SARA
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$485,066
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS086965-02
|
|
Accelerated depletion of hippocampal neural stem cells in neurological disease
|
CHIN, JEANNIE
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$396,509
|
|
Alzheimer's Disease
|
2015
|
NIA
|
3U01AG024904-10S1
|
|
Alzheimer's Disease Neuroimaging Initiative
|
WEINER, MICHAEL
|
NORTHERN CALIFORNIA INSTITUTE/RES/EDU
|
CA
|
$2,500,790
|
|
Alzheimer's Disease
|
2015
|
NIGMS
|
5R01GM099718-04
|
|
Mechanisms of amyloid nucleation
|
WETZEL, RONALD
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$287,850
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS076308-05
|
|
Immunotherapy against tauopathy in a transgenic mouse model
|
MORGAN, DAVID
|
UNIVERSITY OF SOUTH FLORIDA
|
FL
|
$358,823
|
|
Alzheimer's Disease
|
2015
|
NICHD
|
1R21HD079823-01A1
|
|
Synaptic Actin Regulatory Proteins in Down Syndrome
|
LAUTERBORN, JULIE
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
CA
|
$231,750
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R21AG048233-01A1
|
|
A Model-Based Approach to Understanding Memory Impairments in Normal Aging
|
KAHANA, MICHAEL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$240,000
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R21AG046580-01A1
|
|
Cholinergic overload and resilience to attentional capacities in aging
|
PARIKH, VINAY
|
TEMPLE UNIV OF THE COMMONWEALTH
|
PA
|
$225,600
|
|
Alzheimer's Disease
|
2015
|
NHLBI
|
2R01HL096917-05
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5
|
MOSLEY, THOMAS
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
MS
|
$263,346
|
|
Alzheimer's Disease
|
2015
|
NIA
|
2R01HL096917-05
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5
|
MOSLEY, THOMAS
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
MS
|
$150,000
|
|
Alzheimer's Disease
|
2015
|
NIDCD
|
2R01HL096917-05
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5
|
MOSLEY, THOMAS
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
MS
|
$75,000
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
2R01HL096917-05
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5
|
MOSLEY, THOMAS
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
MS
|
$300,000
|
|
Alzheimer's Disease
|
2015
|
NHLBI
|
2R01HL096902-05
|
|
ARIC Neurocognitive Study (ARIC-NCS)
|
ALONSO, ALVARO
|
UNIVERSITY OF MINNESOTA
|
MN
|
$181,798
|
|
Alzheimer's Disease
|
2015
|
NIA
|
2R01HL096902-05
|
|
ARIC Neurocognitive Study (ARIC-NCS)
|
ALONSO, ALVARO
|
UNIVERSITY OF MINNESOTA
|
MN
|
$150,000
|
|
Alzheimer's Disease
|
2015
|
NIDCD
|
2R01HL096902-05
|
|
ARIC Neurocognitive Study (ARIC-NCS)
|
ALONSO, ALVARO
|
UNIVERSITY OF MINNESOTA
|
MN
|
$75,000
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
2R01HL096902-05
|
|
ARIC Neurocognitive Study (ARIC-NCS)
|
ALONSO, ALVARO
|
UNIVERSITY OF MINNESOTA
|
MN
|
$300,000
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R03AG047580-01A1
|
|
Optimizing Outcome Measures for Clin. Trials in Pre-Clinical Alzheimer's Disease
|
EDLAND, STEVEN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$77,500
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5K23AG044431-02
|
|
Optimizing measures of subjective and objective decline in preclinical AD
|
AMARIGLIO, REBECCA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$135,912
|
|
Alzheimer's Disease
|
2015
|
NIGMS
|
5R01GM104130-02
|
|
Design of antibody fragments specific for amyloidogenic aggregates
|
TESSIER, PETER
|
RENSSELAER POLYTECHNIC INSTITUTE
|
NY
|
$264,072
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS037853-18
|
|
OVEREXPRESSION OF APP AND CEREBROVASCULAR REGULATION
|
IADECOLA, COSTANTINO
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$369,688
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS076815-04
|
|
Endocannabinoids in Neurodegenerative Diseases
|
CHEN, CHU
|
LSU HEALTH SCIENCES CENTER
|
LA
|
$315,000
|
|
Alzheimer's Disease
|
2015
|
NIA
|
1R21AG047502-01A1
|
|
Function of the TREM2 R47H variant associated with risk of Alzheimer's disease
|
HAMERMAN, JESSICA
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
WA
|
$256,500
|
|
Alzheimer's Disease
|
2015
|
NIBIB
|
5R03EB016923-02
|
|
Ultra-high resolution BOLD fMRI of medial temporal lobe at 7 Tesla
|
DAS, SANDHITSU
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$80,000
|
|
Alzheimer's Disease
|
2015
|
NHLBI
|
2R01HL096812-05
|
|
ARIC Neurocognitive Study (ARIC-NCS) 1 of 5
|
CORESH, JOSEF
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$709,027
|
|
Alzheimer's Disease
|
2015
|
NIA
|
2R01HL096812-05
|
|
ARIC Neurocognitive Study (ARIC-NCS) 1 of 5
|
CORESH, JOSEF
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$150,000
|
|
Alzheimer's Disease
|
2015
|
NIDCD
|
2R01HL096812-05
|
|
ARIC Neurocognitive Study (ARIC-NCS) 1 of 5
|
CORESH, JOSEF
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$200,000
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
2R01HL096812-05
|
|
ARIC Neurocognitive Study (ARIC-NCS) 1 of 5
|
CORESH, JOSEF
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$300,000
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS074874-05
|
|
Spatio temporal relationship of pathology and functional decline with tauopathy
|
DUFF, KAREN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$453,444
|
|
Alzheimer's Disease
|
2015
|
OD
|
1S10OD020039-01
|
|
Upgrade Siemens MAGNETOM Trio to MAGNETOM Prisma Fit 3T Human MRI System
|
BUCKNER, RANDY
|
HARVARD UNIVERSITY
|
MA
|
$600,000
|
|
Alzheimer's Disease
|
2015
|
NHLBI
|
2R01HL096899-05
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal UNC 4 of 5
|
COUPER, DAVID
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$404,529
|
|
Alzheimer's Disease
|
2015
|
NIA
|
2R01HL096899-05
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal UNC 4 of 5
|
COUPER, DAVID
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$150,000
|
|
Alzheimer's Disease
|
2015
|
NIDCD
|
2R01HL096899-05
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal UNC 4 of 5
|
COUPER, DAVID
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$75,000
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
2R01HL096899-05
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal UNC 4 of 5
|
COUPER, DAVID
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$300,000
|
|
Alzheimer's Disease
|
2015
|
NHLBI
|
2R01HL096814-05
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal 4 of 5
|
WAGENKNECHT, LYNNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$178,747
|
|
Alzheimer's Disease
|
2015
|
NIA
|
2R01HL096814-05
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal 4 of 5
|
WAGENKNECHT, LYNNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$150,000
|
|
Alzheimer's Disease
|
2015
|
NIDCD
|
2R01HL096814-05
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal 4 of 5
|
WAGENKNECHT, LYNNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$75,000
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
2R01HL096814-05
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal 4 of 5
|
WAGENKNECHT, LYNNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$300,000
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG027161-08
|
|
Wisconsin Registry for Alzheimer's Prevention: Biomarkers for Preclinical AD
|
JOHNSON, STERLING
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$834,297
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS045860-14
|
|
ACAT inhibitors regulate palmitoylated APP and Abeta production
|
TANZI, RUDOLPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$368,970
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R01NS076291-05
|
|
Neuronal dysfunction caused by Abeta inhibition of MT motors
|
POTTER, HUNTINGTON
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$321,563
|
|
Alzheimer's Disease
|
2015
|
NIA
|
4R37AG037319-06
|
|
Role of Cyclophilin D in Abeta- induced synaptic injury
|
YAN, SHIDU
|
UNIVERSITY OF KANSAS LAWRENCE
|
KS
|
$307,500
|
|
Alzheimer's Disease
|
2015
|
NHLBI
|
1R01HL122658-01A1
|
|
Determinants of Midlife & Longitudinal Change in Cognitive Function: CARDIA Study
|
SIDNEY, STEPHEN
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
CA
|
$758,123
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5F31AG046087-02
|
|
Regulation of Gamma-Secretase by Substrate Inhibitory Domains
|
BRANDES, ALISSA
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$43,120
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG027297-09
|
|
Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease
|
NORRIS, CHRISTOPHER
|
UNIVERSITY OF KENTUCKY
|
KY
|
$290,392
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG037483-05
|
|
Goals of Care: A Nursing Home Trial of Decision Support for Advanced Dementia
|
HANSON, LAURA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$225,594
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5K99AG047334-02
|
|
High-resolution multimodal imaging of episodic memory networks in aging.
|
HERSHMAN, ILANA
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
CA
|
$105,633
|
|
Alzheimer's Disease
|
2015
|
NIMH
|
5R01MH080007-07
|
|
Neuronal Synchronization in the Medial Temporal Lobe and Memory Formation
|
BUFFALO, ELIZABETH
|
UNIVERSITY OF WASHINGTON
|
WA
|
$493,400
|
|
Alzheimer's Disease
|
2015
|
NINDS
|
5R00NS073936-04
|
|
Protein fate in neurodegeneration: Investigations of novel regulatory mechanisms
|
SCAGLIONE, KENNETH
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$248,295
|
|
Alzheimer's Disease
|
2015
|
NINR
|
5R00NR013593-04
|
|
Inflammation and delayed cognitive dysfunction after stroke
|
DOYLE, KRISTIAN
|
UNIVERSITY OF ARIZONA
|
AZ
|
$190,404
|
|
Alzheimer's Disease
|
2015
|
NIGMS
|
5SC3GM099635-04
|
|
Interaction between Alzheimer's beta-Amyloid Peptide and Phospholipid Bilayers
|
PERIC, MIROSLAV
|
CALIFORNIA STATE UNIVERSITY NORTHRIDGE
|
CA
|
$108,750
|
|
Alzheimer's Disease
|
2015
|
NIMH
|
5P50MH100024-03
|
5682
|
Intracellular Stores of Calcium and Plasticity at the Excitatory Synapse
|
WORLEY, PAUL
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$291,668
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5U24AG041689-04
|
|
The NIA Genetics of Alzheimer's Disease Data Storage Site
|
WANG, LI-SAN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$1,591,025
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG041797-04
|
|
Epidemiology of Familial Late-Onset Alzheimer's Disease
|
MAYEUX, RICHARD
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$824,265
|
|
Alzheimer's Disease
|
2015
|
NICHD
|
5P01HD029587-20
|
7044
|
PROJECT 1 - MOLECULAR ANALYSIS OF NMDA RECEPTOR MODULATORY SITES
|
LIPTON, STUART
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
CA
|
$125,882
|
|
Alzheimer's Disease
|
2015
|
NICHD
|
5P01HD029587-20
|
7045
|
PROJECT II - CLINICALLY-SAFE NMDAR ANTAGONISTS PREVENT NEUROTOXICITY
|
LIPTON, STUART
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
CA
|
$136,387
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R37AG006647-27
|
|
Glutamate receptors in aging cortical circuits
|
MORRISON, JOHN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$494,447
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P01AG010770-22
|
8542
|
SCIENCE
|
PRUSINER, STANLEY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$242,708
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P01AG010770-22
|
8543
|
PATHOLOGY
|
PRUSINER, STANLEY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$145,372
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P01AG010770-22
|
8547
|
Analysis of Neurodegenerative Mechanisms Using Human and Mous iN Cells
|
PRUSINER, STANLEY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$293,929
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG039478-05
|
|
Targeted Proteomics of Resilient Cognition in Aging
|
ARNOLD, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$520,597
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5K01AG044490-02
|
|
Peripheral & Brain Cholesterol Metabolism in Neurodegenerative Mouse Models
|
FITZ, NICHOLAS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$92,587
|
|
Alzheimer's Disease
|
2015
|
NIDDK
|
5K23DK094982-04
|
|
NEURAL RESPONSE TO INSULIN RESISTANCE TREATMENTS
|
HASSENSTAB, JASON
|
WASHINGTON UNIVERSITY
|
MO
|
$163,166
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG041716-04
|
|
From Evidence-Base to Practice: Implementing RDAD in AAA Community-Based Services
|
TERI, LINDA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$548,217
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG040770-04
|
|
Imaging and genetic biomarkers for Alzheimer's disease
|
APOSTOLOVA, LIANA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$250,551
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5R01AG041851-04
|
|
Validating the New Criteria for Preclinical Alzheimer's disease
|
JACK, CLIFFORD
|
MAYO CLINIC ROCHESTER
|
MN
|
$507,281
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5U01AG046871-03
|
|
Neuropathologic research on dementia using Nun Study and HAAS data
|
MONTINE, THOMAS
|
UNIVERSITY OF WASHINGTON
|
WA
|
$662,945
|
|
Alzheimer's Disease
|
2015
|
NIMH
|
5K23MH095971-04
|
|
Insulin Resistance in Late-Life Depression
|
MARANO, CHRISTOPHER
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$182,172
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG005131-32
|
5881
|
Core A: Administrative Core
|
GALASKO, DOUGLAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$642,584
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG005131-32
|
5882
|
Clinical Core
|
GALASKO, DOUGLAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$904,344
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG005131-32
|
5883
|
Data Management and Statistical Core
|
EDLAND, STEVEN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$257,140
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG005131-32
|
5884
|
Neuropathology Core
|
MASLIAH, ELIEZER
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$261,853
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG005131-32
|
5885
|
Outreach, Recruitment and Education Core
|
COREY-BLOOM, JODY
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$209,538
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG005131-32
|
5886
|
Hispanic Satellite Core
|
GOLLAN, TAMAR
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$310,019
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG005131-32
|
5887
|
Probing SORL1 Risk Factors with Human Induced Pluripotent Stem Cell Technology
|
GOLDSTEIN, LAWRENCE
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$153,667
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG005131-32
|
5888
|
Project 2: Disease Mechanisms in Frontotemporal Dementia Linked to C9orf72 Expans
|
LAGIER-TOURENNE, CLOTILDE
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$180,577
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG005134-32
|
5899
|
Core A: Administrative Core
|
HYMAN, BRADLEY
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$509,954
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG005134-32
|
5900
|
Core B - Clinical Core
|
GOMEZ-ISLA, TERESA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$758,327
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG005134-32
|
5901
|
Core C - Data Management and Statistics
|
BETENSKY, REBECCA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$195,150
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG005134-32
|
5902
|
Core D - Neuropathology Core
|
FROSCH, MATTHEW
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$221,684
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG005134-32
|
5903
|
Core E - Outreach, Recruitment and Education Core
|
SPERLING, REISA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$156,145
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG005134-32
|
5904
|
Core F - Neuroimaging Core
|
SPERLING, REISA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$170,652
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG005134-32
|
5905
|
Neural Correlates of Cognitive Prodromes in Neurodegenerative Dementias
|
HEDDEN, JULIUS
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$210,973
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG005134-32
|
5906
|
Brain Amyloid Accrual in Non Demented People: Preclinical AD or Brain Resilience
|
GOMEZ-ISLA, TERESA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$210,973
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG005134-32
|
5907
|
Mouse Model of Early Alzheimer's Disease
|
HYMAN, BRADLEY
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$202,359
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG023501-12
|
5929
|
Core A: Administrative Core
|
MILLER, BRUCE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$341,772
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG023501-12
|
5930
|
Core B: Clinical Core
|
KRAMER, JOEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$386,999
|
|
Alzheimer's Disease
|
2015
|
NIA
|
5P50AG023501-12
|
5932
|
Core C: Data Management and StatisticalCore
|
YAFFE, KRISTINE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$153,495
|
|
